Paranyline

Paranyline

SCHEMBL25564

N=C(N)c1ccc(C=C2c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.53
PRMT1 Q99873 1/20 0.53
ALDH1A1 P00352 1/20 0.53
HPGD P15428 1/20 0.53
CYP2C19 P33261 1/20 0.53
HSD17B10 Q99714 1/20 0.53
F2 P00734 13/20 0.49
F10 P00742 13/20 0.49
CYP19A1 P11511 1/20 0.48
CYP11B2 P19099 1/20 0.48
F12 P00748 1/20 0.48
F7 P08709 1/20 0.48
F3 P13726 1/20 0.48
PKM P14618 1/20 0.48
WDR5 P61964 1/20 0.47
BLM P54132 1/20 0.47
PLAU P00749 1/20 0.46
HPN P05981 1/20 0.46
PRSS1 P07477 1/20 0.45
PRSS2 P07478 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Paranyline SCHEMBL29382327 1.00 PRMT5 (0.53) PRMT5PRMT1ALDH1A1HPGDCYP2C19
Paranyline SCHEMBL43643 0.98 PRMT5 (0.52) PRMT5PRMT1ALDH1A1HPGDCYP2C19
Paranyline SCHEMBL30170073 0.98 PRMT5 (0.52) PRMT5PRMT1ALDH1A1HPGDCYP2C19
SCHEMBL11733756 0.74 CYP19A1 (0.48) ALDH1A1HPGDCYP2C19CYP19A1CYP11B2
SCHEMBL283216 0.73 CYP19A1 (0.67) ALDH1A1HPGDHSD17B10CYP19A1CYP11B2
SCHEMBL428473 0.72 PRMT1 (0.83) PRMT5PRMT1ALDH1A1HPGDCYP2C19
SCHEMBL428474 0.72 PRMT1 (0.83) PRMT5PRMT1ALDH1A1HPGDCYP2C19
Hydrochloric Acid SCHEMBL11333164 0.71 PRMT1 (0.79) PRMT5PRMT1ALDH1A1HPGDCYP2C19
Hydrochloric Acid SCHEMBL11333159 0.71 PRMT1 (0.79) PRMT5PRMT1ALDH1A1HPGDCYP2C19
Stilbamidine SCHEMBL208655 0.71 PRMT1 (1.00) PRMT5PRMT1ALDH1A1HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4336 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132153-A1 METHOD FOR PREPARING AND PURIFYING 4-BORONO-L-PHENYLALANINE SCI PHARMTECH, INC. (TW) 2026-05-14 US claimed
US-20240041935-A1 PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS CREATIVE MEDICAL TECHNOLOGIES, INC. (US) 2024-02-08 US claimed
EP-4034087-A1 LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS DDS Research Inc. (CA) 2022-08-03 EP claimed
US-20220218611-A1 LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS DDS RESEARCH INC. (CA) 2022-07-14 US claimed
WO-2021056106-A1 LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS DDS RESEARCH INC. (CA) 2021-04-01 WO claimed
US-20200323883-A1 METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS ENTERIN, INC. (US) 2020-10-15 US claimed
US-10478444-B2 Methods and compositions for treating and preventing viral infections ENTERIN, INC. (US) 2019-11-19 US claimed
US-20180133230-A1 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTIONS ENTERIN LABORATORIES, INC. (US) 2018-05-17 US claimed
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
US-20140328792-A1 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTIONS ENTERIN, INC. 2014-11-06 US claimed
EP-0786999-A4 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO INC (US) 1999-01-20 EP claimed
EP-0792371-A4 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO INC (US) 1998-12-30 EP claimed
US-5811078-A IN A SOLVENT MIXTURE WITH ETHYL OR ISOPROPYL ALCOHOL AND WATER ADOLOR CORPORATION (US) 1998-09-22 US claimed
EP-0852494-A2 PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-07-15 EP claimed
EP-0792371-A1 COMBINATION METHOD FOR ACNE TREATMENT Merck & Co., Inc. (US) 1997-09-03 EP claimed
EP-0786999-A1 COMBINATION METHOD FOR ACNE TREATMENT Merck & Co., Inc. (US) 1997-08-06 EP claimed
WO-1997009973-A2 PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-03-20 WO claimed
US-5543417-A 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent MERCK & CO., INC. (US) 1996-08-06 US claimed
WO-1996012487-A1 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO., INC. (US) 1996-05-02 WO claimed
WO-1996012817-A1 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO., INC. (US) 1996-05-02 WO claimed